MOUNTAIN VIEW, Calif., Dec. 29 (UPI) -- A California biopharmaceutical company has submitted a government application for a new weight-loss drug, officials said Tuesday.
WASHINGTON, April 2 (UPI) -- The U.S. Food and Drug Administration has approved the first generic versions of Topamax tablets (topiramate) to prevent seizures.
WASHINGTON, Sept. 5 (UPI) -- The U.S. Food and Drug Administration announced approval Wednesday of the first generic versions of the blood pressure and heart medication Coreg.
WASHINGTON, July 2 (UPI) -- The U.S. Food and Drug Administration has approved the first generic versions of Lamisil (terbinafine hydrochloride) tablets to treat nail fungus infection.
WASHINGTON, April 24 (UPI) -- The U.S. Food and Drug Administration has approved the first generic versions of Ambien (zolpidem tartrate) for the treatment of insomnia.
SAN FRANCISCO, Sept. 29 (UPI) -- U.S. firm Vivus' topical drug Alista, a therapy for female sexual arousal disorder, will be retested in women who have had hysterectomies.
MOUNTAIN VIEW, Calif., May 10 (UPI) -- Vivus said Wednesday it has seen positive findings from phase 2 studies of its new oral obesity treatment Qnexa.
REYKJAVIK, Iceland, Oct. 18 (UPI) -- Iceland's Actavis Group will pay $810 million to buy Alpharma Inc.'s generic drug business.
